nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A novel adjuvant Ling Zhi-8 enhances the efficacy of DNA cancer vaccine by activating dendritic cells
|
Lin, Chi-Chen |
|
2011 |
60 |
7 |
p. 1019-1027 |
artikel |
2 |
A novel adjuvant Ling Zhi-8 enhances the efficacy of DNA cancer vaccine by activating dendritic cells
|
Lin, Chi-Chen |
|
|
60 |
7 |
p. 1019-1027 |
artikel |
3 |
B7-H4 expression associates with cancer progression and predicts patient’s survival in human esophageal squamous cell carcinoma
|
Chen, Lu-jun |
|
2011 |
60 |
7 |
p. 1047-1055 |
artikel |
4 |
Enhanced anti-tumor immunity by superantigen-pulsed dendritic cells
|
Kato, Masato |
|
2011 |
60 |
7 |
p. 1029-1038 |
artikel |
5 |
Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma
|
Souza Malaspina, Tatiana Salles de |
|
2011 |
60 |
7 |
p. 965-974 |
artikel |
6 |
Expression of cancer testis antigens in human BRCA-associated breast cancers: potential targets for immunoprevention?
|
Adams, Sylvia |
|
2011 |
60 |
7 |
p. 999-1007 |
artikel |
7 |
Gastric type I carcinoid: a pilot study with human G17DT immunogen vaccination
|
Tieppo, Chiara |
|
2011 |
60 |
7 |
p. 1057-1060 |
artikel |
8 |
High susceptibility of c-KIT+CD34+ precursors to prolonged doxorubicin exposure interferes with Langerhans cell differentiation in a human cell line model
|
Ven, Rieneke van de |
|
2011 |
60 |
7 |
p. 943-951 |
artikel |
9 |
Identification of Hydroxysteroid (17β) dehydrogenase type 12 (HSD17B12) as a CD8+ T-cell-defined human tumor antigen of human carcinomas
|
Visus, Carmen |
|
2011 |
60 |
7 |
p. 919-929 |
artikel |
10 |
Identification of MAGE-C1 (CT-7) epitopes for T-cell therapy of multiple myeloma
|
Anderson, Larry D. |
|
2011 |
60 |
7 |
p. 985-997 |
artikel |
11 |
Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer
|
Ladoire, Sylvain |
|
2011 |
60 |
7 |
p. 909-918 |
artikel |
12 |
Soluble MUC1 and serum MUC1-specific antibodies are potential prognostic biomarkers for platinum-resistant ovarian cancer
|
Budiu, Raluca A. |
|
2011 |
60 |
7 |
p. 975-984 |
artikel |
13 |
Soluble MUC1 and serum MUC1-specific antibodies are potential prognostic biomarkers for platinum-resistant ovarian cancer
|
Budiu, Raluca A. |
|
|
60 |
7 |
p. 975-984 |
artikel |
14 |
Successful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-alpha
|
Verdegaal, Els M. E. |
|
2011 |
60 |
7 |
p. 953-963 |
artikel |
15 |
Targeting tumor vasculature with novel Listeria-based vaccines directed against CD105
|
Wood, Laurence M. |
|
2011 |
60 |
7 |
p. 931-942 |
artikel |
16 |
The CD40 agonist antibody CP-870,893 enhances dendritic cell and B-cell activity and promotes anti-tumor efficacy in SCID-hu mice
|
Gladue, Ronald P. |
|
2011 |
60 |
7 |
p. 1009-1017 |
artikel |
17 |
Tumor-derived interleukin-10 as a prognostic factor in stage III patients undergoing adjuvant treatment with an autologous melanoma cell vaccine
|
Mahipal, Amit |
|
2011 |
60 |
7 |
p. 1039-1045 |
artikel |